Sanofi (SNY) EBITDA Margin (QoQ) (2009 - 2026)

Sanofi (SNY) EBITDA Margin (QoQ) (2009 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Sanofi - - 9.49 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 25,111.00
Dec 31, 2025 -25,216.00
Sep 30, 2025 -460.00
Jun 30, 2025 291.00
Mar 31, 2025 -24,287.00
Dec 31, 2024 25,167.00
Sep 30, 2024 -1,068.00
Jun 30, 2024 -318.00
Mar 31, 2024 1,182.00
Dec 31, 2023 137.00
Sep 30, 2023 -803.00
Jun 30, 2023 39.00
Mar 31, 2023 -6,912.00
Dec 31, 2022 7,576.00
Sep 30, 2022 -934.00
Jun 30, 2022 606.00
Mar 31, 2022 -10,933.00
Dec 31, 2021 11,527.00
Sep 30, 2021 -559.00
Jun 30, 2021 129.00